Van Miert Sabine, Van Dyck Stefaan, Schmidt Thomas J, Brun Reto, Vlietinck Arnold, Lemière Guy, Pieters Luc
Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium.
Bioorg Med Chem. 2005 Feb 1;13(3):661-9. doi: 10.1016/j.bmc.2004.10.058.
A series of synthetic dihydrobenzofuran lignans and related benzofurans were evaluated for their cytotoxicity in a screening panel consisting of various human tumour cell lines, and for their antiprotozoal activity against L. donovani (axenic amastigotes), chloroquine resistant Plasmodium falciparum (strain K1), Trypanosoma brucei rhodesiense and T. cruzi, and for cytotoxicity on L6 cells. No promising cytotoxicities against human tumour cell lines were observed for newly synthesised compounds, but the dimerisation product of some lipophylic esters of caffeic acid, such as compound 2g, showed a high activity against chloroquine-resistant P. falciparum (strain K1) (IC50 0.43 microg/mL) and L. donovani (axenic amastigotes) (IC50 0.12 microg/mL), which was confirmed in an infected macrophage assay (IC50 0.19 microg/mL). QSAR models for the cytotoxic and antileishmanial activity were generated using Quasar receptor surface modelling.
对一系列合成二氢苯并呋喃木脂素及相关苯并呋喃进行了评估,检测它们在由多种人类肿瘤细胞系组成的筛选组中的细胞毒性,以及对杜氏利什曼原虫(无菌无鞭毛体)、氯喹抗性恶性疟原虫(K1株)、布氏罗得西亚锥虫和克氏锥虫的抗原生动物活性,还有对L6细胞的细胞毒性。新合成的化合物对人类肿瘤细胞系未观察到有前景的细胞毒性,但一些咖啡酸脂溶性酯的二聚产物,如化合物2g,对氯喹抗性恶性疟原虫(K1株)(IC50 0.43微克/毫升)和杜氏利什曼原虫(无菌无鞭毛体)(IC50 0.12微克/毫升)显示出高活性,这在感染巨噬细胞试验中得到证实(IC50 0.19微克/毫升)。使用Quasar受体表面建模生成了细胞毒性和抗利什曼原虫活性的QSAR模型。